INTEGRA: A Vanguard Study of Health Service Delivery in a Mobile Health Delivery Unit
Status:
Enrolling by invitation
Trial end date:
2024-11-30
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine the efficacy of using a mobile health delivery unit
("mobile unit") to deliver "one stop" integrated health services - particularly medication
for opioid use disorder (MOUD) and medication for HIV treatment and prevention - to people
who inject drugs (PWID) with opioid use disorder (OUD) to improve uptake and use of MOUD, and
uptake and use of antiretroviral therapy (ART) or pre-exposure prophylaxis (PrEP).
Phase:
N/A
Details
Lead Sponsor:
HIV Prevention Trials Network
Collaborators:
National Institute of Allergy and Infectious Diseases (NIAID) National Institute on Drug Abuse (NIDA)